Bandingkan Harga & Kinerja Greenwood Sejahtera Tbk. (GWSA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Greenwood Sejahtera Tbk. dan Organon Pharma Indonesia Tbk.: Greenwood Sejahtera Tbk. diperdagangkan di Rp167 (kapitalisasi pasar 1,34 T, volume 24 jam 929,4 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Greenwood Sejahtera Tbk. jauh lebih besar — sekitar 12,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| GWSA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,34 T | 104,4 M |
Volume | 929,4 rb | — |
Lot | 9,29 rb | — |
Perputaran | 156,04 jt | — |
Harga Rata-rata | 167,89 | — |
Nilai Transaksi | 156,04 jt | — |
Harga Ekuilibrium Indikatif | 167 | — |
Volume Ekuilibrium Indikatif | 15 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Greenwood Sejahtera Tbk.
Greenwood Sejahtera is part of KG Global Development. On the begining, the company have a relation with Jababeka group, which own the land that has been used to builit TCC Batavia.PT Greenwood Sejahtera, company that developing The City Center Batavia (TCC Batavia), on December 23, 2011. The City Center Batavia is a superblock, mix used development project on top of 2,1 hectares of land. Its first tower is a skycrapper building: a tower with 46 storey, plus an 8 storey annex. According to the masterplan, Greenwood Sejahtera will build 3 tower on the site. The other tower will be completed in 2017 and the area will be expanded to 5.4 hectares. Its ground breaking ceremony is on September 12, 2009.
Selengkapnya di halaman GWSA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
